M3, Inc. Not Provides Earnings Guidance for the Year Ending March 31, 2022
April 23, 2021 at 02:00 am EDT
Share
M3, Inc. not provided earnings guidance for the year ending March 31, 2022. For the year, the company Forecasts for the fiscal year ending March 31, 2022 are undisclosed due to inability to reasonably estimate domestic and overseas business impact from the global COVID-19 pandemic. Forecasts will be promptly released as soon as conditions allow for reasonable estimates.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, INC. 
